| abstract |
The "use of Bacillus coagulans BC99 in the preparation of a product for relieving colitis or an immunomodulatory product" of the invention belongs to the technical field of microorganisms. The present invention provides Bacillus coagulans BC99 with a deposit number of CGMCC No. 21801 in inhibiting Shigella flexneri and/or using Ellman's reagent or propionate ketone salt or ancient sugar and/or preparing diarrhea-relieving products or colitis-relieving products or The use of immunomodulatory products or products for regulating intestinal flora, and it has been confirmed that Bacillus coagulans BC99 can promote the growth of beneficial microorganisms such as Bifidobacterium, inhibit the growth of harmful microorganisms such as Shigella flexneri, and improve intestinal immunity , such as increasing the expression level of IL-10, and effectively alleviating colitis, such as restoring colon length, etc. have significant effects. |